MiƱao, Oliver A.
HRN: 21-34-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
06/09/2023
06/15/2023
PO
1.8 Ml
BID
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes